Lithium’s Effects on the Brain: A Scientific Look

Lithium reshapes the brain through an unusually wide set of mechanisms: it grows new neurons, increases gray matter volume, dampens neuroinflammation, and strengthens the connections between brain regions responsible for emotional control. Prescribed for decades as the gold-standard treatment for bipolar disorder, it remains one of the most studied psychiatric drugs in neuroscience, yet researchers are still cataloguing the full scope of what it does once it crosses the blood-brain barrier. The picture that emerges from the literature is striking, because lithium does not simply tweak one neurotransmitter system the way most psychiatric medications do. It acts on fundamental cellular machinery in ways that touch nearly every aspect of brain health.

The Molecular Targets Behind Everything Else

Understanding the rest of lithium’s brain effects starts with two key molecular actions. First, lithium inhibits an enzyme called GSK-3, a signaling molecule involved in cell survival, growth, inflammation, and how neurons respond to stimuli. GSK-3 sits at a crossroads of so many cellular pathways that blocking it sends ripple effects across brain function.¹ Second, lithium inhibits inositol monophosphatase, an enzyme that recycles a signaling molecule called inositol. When this recycling slows down, cells that are firing too rapidly lose some of their fuel for continued signaling, which is thought to be one reason lithium calms the overactive neural circuits seen in mania.² These two actions, GSK-3 inhibition and inositol depletion, are the upstream events that drive most of the downstream brain changes researchers have documented.³

Growing New Brain Cells

One of lithium’s most remarkable effects is its ability to stimulate the birth of new neurons in the hippocampus, a brain region critical for memory and mood regulation. In an early and widely cited mouse study, chronic lithium treatment produced a roughly 25% increase in newly dividing cells in the dentate gyrus, a hippocampal subregion where adult neurogenesis occurs. About two-thirds of those new cells went on to become neurons.⁴ This was not just a curiosity of mouse biology. A study using human hippocampal progenitor cells found that lithium treatment increased the generation of neuroblasts and neurons, alongside genes that regulate the volume of a specific hippocampal layer. The researchers concluded that neurogenesis is a plausible mechanism behind the hippocampal volume increases observed in lithium-treated patients.⁵

The neurogenesis pathway appears to run through GSK-3 inhibition. In a mouse model of Alzheimer’s disease, lithium stimulated the growth and neuronal specialization of new cells and reversed cognitive impairments caused by amyloid pathology. The researchers traced this effect to GSK-3β inhibition and subsequent activation of a growth-promoting signaling cascade.⁶ This connection between lithium, GSK-3, and new neuron growth is one of the best-established chains in lithium neuroscience.

Measurable Increases in Gray Matter

The neurogenesis findings help explain a structural observation that initially surprised researchers: lithium physically increases the volume of gray matter in the brain. A longitudinal imaging study tracked patients with bipolar disorder over 16 weeks of lithium treatment and found sustained increases in gray matter volume, peaking around weeks 10 to 12. Patients whose gray matter increased the most also tended to show the best clinical improvement.⁷

This is not limited to people with psychiatric illness. A study of healthy volunteers given lithium found significant gray matter increases in the left and right dorsolateral prefrontal cortex and the left anterior cingulate, regions involved in decision-making, attention, and emotional regulation. Total white matter volume also increased.⁸ These findings suggest that lithium’s brain-building effects are not simply correcting a deficit caused by bipolar disorder but may reflect something more general about how lithium supports neural tissue.

Quieting Brain Inflammation

Chronic inflammation in the brain, driven primarily by overactive immune cells called microglia, is increasingly recognized as a contributor to mood disorders, neurodegeneration, and cognitive decline. Lithium appears to put the brakes on this process through several routes. In cell culture experiments, lithium dose-dependently reduced microglial activation: at therapeutic concentrations, the proportion of activated microglia dropped substantially, and the release of inflammatory signaling molecules fell in tandem.⁹

More recent work has identified the inflammasome, a molecular complex that amplifies inflammatory responses, as another target. Lithium treatment significantly reduced the expression of genes related to inflammasome activity, suggesting it may help prevent the inflammatory cascade from gaining momentum in the first place.¹⁰ A narrative review synthesizing animal, cell culture, and clinical evidence concluded that lithium reduces pro-inflammatory markers and enhances anti-inflammatory responses in both laboratory models and in patients with bipolar disorder.¹¹

Protecting Neurons from Damage

Beyond growing new cells and dampening inflammation, lithium shields existing neurons from several forms of harm. One of the best-studied protective effects involves glutamate excitotoxicity, a process where excessive stimulation by the neurotransmitter glutamate damages and kills neurons. Pretreating cortical neurons with lithium at therapeutic concentrations provided near-complete protection against this kind of damage, primarily by reducing calcium flooding through a specific type of glutamate receptor.¹²

Lithium also appears to protect against the specific pathological processes of Alzheimer’s disease. It inhibits hyperphosphorylation of tau protein and protects cultured neurons from cell death triggered by beta-amyloid, the two hallmark molecules of Alzheimer’s pathology.¹³ A systematic review of this area concluded that lithium reduces amyloid deposition and tau phosphorylation in animal models and may reverse associated cognitive deficits.¹⁴ At the mitochondrial level, lithium has been shown to boost energy production in neurons carrying Alzheimer’s-associated mutations, increasing oxygen consumption and ATP output in cells that would otherwise be energy-starved.¹⁵

Lithium also enhances autophagy, the cellular housekeeping process that clears out damaged proteins and organelles. This cleanup mechanism is relevant to neurodegenerative diseases like Huntington’s and Parkinson’s, where toxic protein aggregates accumulate inside neurons.¹⁶

Rewiring Emotional Circuits

Brain imaging studies have moved beyond simple volume measurements to look at how lithium changes the way different brain regions communicate with each other. The picture that emerges is one of normalization: lithium tends to push aberrant connectivity patterns back toward healthy baselines. A systematic review of neuroimaging findings in bipolar disorder found that lithium increased connectivity between the amygdala (the brain’s threat and emotion detector) and the prefrontal cortex (responsible for top-down emotional regulation). In depressed patients, lithium boosted underactive connections; in manic patients, it dialed back overactive ones. Both changes correlated with clinical improvement.¹⁷

An updated review of functional MRI studies reached a consistent conclusion: across different experimental tasks and resting-state measurements, lithium normalizes activity in prefrontal regions and their connections to emotion-processing areas. The pattern suggests that lithium does not simply sedate emotional reactivity but fine-tunes the brain’s ability to regulate it.¹⁸

Impulse Control and Suicide Prevention

Lithium’s well-documented anti-suicidal effect has long been one of its most clinically important properties, but the brain mechanism behind it remained unclear until recently. A study of people who had survived a life-threatening suicide attempt found that lithium treatment strengthened brain electrical signals tied to decision-making and impulse control. In practical terms, patients showed improved decision-making after treatment, with corresponding changes in brain activity that gave them more time to pause before acting on an impulse.¹⁹ This offers a neurological explanation for what clinicians have observed for decades: people on lithium are less likely to act on suicidal urges, possibly because the drug strengthens the brain circuitry responsible for putting the brakes on impulsive action.

The Cognitive Trade-Off

For all its brain-building and neuroprotective properties, lithium is not without cognitive costs. Many people taking lithium report a subtle dulling of mental sharpness, and controlled research supports this observation. A double-blind study of healthy volunteers found that lithium mildly impaired short-term memory and word recall compared to placebo. Performance was worst during active treatment and improved after lithium was stopped.²⁰ The effects were described as mild and selective, not the dramatic cognitive fog patients sometimes fear, but real enough to notice. This trade-off matters because some people discontinue lithium specifically because of perceived cognitive side effects, which can lead to mood episode relapse. The emerging evidence that lithium also protects the brain from long-term degeneration complicates this calculation: a small short-term cost to mental sharpness may coexist with a larger long-term benefit to brain health.

Where Lithium Goes Inside the Brain

For most of lithium’s clinical history, researchers could not see where the drug actually concentrated within the brain. That changed with the development of lithium-7 MRI, a specialized imaging technique that directly maps lithium distribution inside the skull. Early work demonstrated that lithium does not spread evenly: its concentration varies across brain regions, and this variation differs from person to person.²¹ A subsequent high-resolution study at 7 Tesla confirmed this heterogeneity and identified the left hippocampus as a region where lithium consistently accumulated at high levels across patients. Brain lithium concentration tracked closely with blood levels but was roughly 40% of the plasma concentration.²²

The hippocampal accumulation finding is interesting because it dovetails with the neurogenesis and volume data: the brain region where lithium concentrates most is the same region where it grows new neurons and increases volume. Whether the drug preferentially enters the hippocampus or whether the hippocampus preferentially retains it remains an open question, but the convergence is hard to ignore.

Trace Lithium in Drinking Water

Perhaps the most surprising chapter in lithium neuroscience involves naturally occurring trace amounts in tap water, concentrations thousands of times lower than a therapeutic dose. Ecological studies have found that communities with higher trace lithium in their water supply tend to have lower rates of both suicide and dementia. A qualitative review covering this literature concluded that higher trace lithium levels appear associated with lower suicide rates and reduced dementia rates.²³ A systematic review focused specifically on dementia found associations with drinking water lithium concentrations as low as 0.002 mg/L, while levels below that threshold did not show the effect.²⁴

These are observational studies, meaning they cannot prove causation. Communities with different lithium levels in their water differ in many other ways too. But the consistency of the association across multiple countries and study designs, combined with the known neuroprotective mechanisms, has generated genuine scientific interest in whether trace-level lithium supplementation could be a public health tool. No randomized trial has tested this at a population level, so the idea remains speculative.

Effects on Circadian Rhythms and Gene Expression

Lithium has a well-known effect on biological clocks, tending to lengthen circadian rhythms in both animals and humans. At the molecular level, it alters the expression of core clock genes: in one study, lithium increased the expression of some clock genes while reducing others and measurably lengthened the period of a key circadian gene.²⁵ This circadian effect may be relevant to bipolar disorder, where disrupted sleep-wake cycles are both a symptom and a trigger of mood episodes. By stabilizing biological rhythms, lithium may help prevent the circadian chaos that precedes mania.

Lithium also reaches into gene regulation through epigenetic mechanisms. It has been shown to alter DNA methylation patterns in human neural progenitor cells, shifting them away from producing support cells and toward producing neurons.²⁶ Separately, exploratory cell studies have found that lithium upregulates genes involved in histone modification, a different layer of gene regulation.²⁷ These epigenetic effects add another dimension to how lithium changes the brain: not just through immediate signaling effects but by altering which genes get turned on or off over time.

When Lithium Damages the Brain

Lithium has a notoriously narrow therapeutic window. The difference between a helpful blood level and a toxic one is small, and when things go wrong, the consequences for the brain can be severe and sometimes permanent. A scoping review of a condition called SILENT (Syndrome of Irreversible Lithium-Effectuated Neurotoxicity) found that the most common presentation involved altered consciousness, ranging from confusion to coma, in about 61% of cases. Slurred speech and unsteady walking appeared in over half of cases, and tremors in about 41%.²⁸

The cerebellum, which coordinates movement and balance, appears especially vulnerable. A case report described a patient whose blood lithium level reached over 4 mmol/L during acute toxicity, more than three times the upper end of the therapeutic range. Although consciousness recovered after treatment, the patient developed permanent cerebellar dysfunction with severe difficulty walking and speaking. Brain imaging showed progressive cerebellar shrinkage over five years of follow-up, even though lithium levels had returned to normal.²⁹ This is the dark mirror of lithium’s brain-building effects: the same drug that grows gray matter under controlled conditions can destroy neural tissue when concentrations spike too high.

This is why lithium treatment requires regular blood monitoring, and why patients are warned about dehydration, kidney problems, and drug interactions that can push lithium levels upward. The therapeutic benefit is real, but the margin of safety is smaller than with most psychiatric medications.

Risks During Early Brain Development

Lithium’s powerful effects on cellular signaling carry particular risks during pregnancy, when the fetal brain is forming. Animal research has shown that lithium exposure during embryonic development can cause neural tube defects, the severe malformations that occur when the brain or spinal cord fails to close properly. In a mouse model, lithium carbonate exposure produced neural tube defects in about a third of embryos, accompanied by abnormal cell proliferation and inhibition of both GSK-3β and inositol monophosphatase in embryonic neural tissue.³⁰ Another study found that lithium disrupted the development of primary cilia, tiny antenna-like structures on cells that are crucial for brain patterning during embryogenesis.³¹

The same molecular targets that make lithium therapeutic in the adult brain, GSK-3 and inositol monophosphatase, are also essential for normal embryonic neural development. Blocking them at the wrong time disrupts the precise choreography of cell division and differentiation that builds a brain from scratch. This is why lithium use during the first trimester of pregnancy requires careful risk-benefit analysis with a specialist, and why the drug is sometimes switched to an alternative during early pregnancy when clinically feasible.